BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30676440)

  • 1. Watch and See Strategy in Selected Neuroblastoma Case Scenarios: Success and Limitations.
    Fawzy M; El Zomor H; El Menawi S; Elkinaai N; Ahmed G; Refaat A; Elahmadawy M; Zaghloul M
    J Pediatr Hematol Oncol; 2019 Aug; 41(6):e384-e387. PubMed ID: 30676440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease.
    Tas ML; Nagtegaal M; Kraal KCJM; Tytgat GAM; Abeling NGGM; Koster J; Pluijm SMF; Zwaan CM; de Keizer B; Molenaar JJ; van Noesel MM
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28061. PubMed ID: 31736229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97.
    Hero B; Simon T; Spitz R; Ernestus K; Gnekow AK; Scheel-Walter HG; Schwabe D; Schilling FH; Benz-Bohm G; Berthold F
    J Clin Oncol; 2008 Mar; 26(9):1504-10. PubMed ID: 18349403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of the "wait and see" approach to localized perinatal adrenal neuroblastoma.
    Cozzi DA; Mele E; Ceccanti S; Natale F; Clerico A; Schiavetti A; Dominici C
    World J Surg; 2013 Feb; 37(2):459-65. PubMed ID: 23135423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Wait and see" strategy in localized neuroblastoma in infants: an option not only for cases detected by mass screening.
    Fritsch P; Kerbl R; Lackner H; Urban C
    Pediatr Blood Cancer; 2004 Nov; 43(6):679-82. PubMed ID: 15390301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage 4S neuroblastoma, a disseminated tumor with excellent outcome.
    Elimam NA; Atra AA; Fayea NY; Al-Asaad TG; Khattab TM; Al-Sulami GA; Felimban SK
    Saudi Med J; 2006 Nov; 27(11):1734-6. PubMed ID: 17106552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
    Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
    Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic 4S neuroblastoma with excellent outcome in Saudi cancer center.
    AlZhrani WA; Elimam NA; Almehdar AS; Bassem SM; Abdullatif DE; Ahmed KD; Baothman AA
    Saudi Med J; 2021 Dec; 42(12):1353-1356. PubMed ID: 34853141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic progression in infants diagnosed with stage 4S neuroblastoma. A study of the Italian Neuroblastoma Registry.
    Parodi S; Sorrentino S; Cataldo AD; Tondo A; Fagnani AM; Perri P; Gigliotti AR; Erminio G; Corrias MV; De Bernardi B
    Pediatr Blood Cancer; 2021 May; 68(5):e28904. PubMed ID: 33459514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies.
    van Noesel MM; Hählen K; Hakvoort-Cammel FG; Egeler RM
    Cancer; 1997 Sep; 80(5):834-43. PubMed ID: 9307181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience of the Izmir Pediatric Oncology Group on Neuroblastoma: IPOG-NBL-92 Protocol.
    Olgun N; Kansoy S; Aksoylar S; Cetingul N; Vergin C; Oniz H; Sarialioglu F; Kantar M; Uysal K; Tuncyurek M; Kargi A; Aktas S; Bayol U; Karaca I; Arikan A; Balik E; Aktug T; Elmas N; Kovanlikaya A; Kinay M; Anacak Y; Degirmenci B; Burak Z
    Pediatr Hematol Oncol; 2003; 20(3):211-8. PubMed ID: 12637217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connatal localized neuroblastoma. The case to delay treatment.
    Kerbl R; Urban CE; Lackner H; Höfler G; Ambros IM; Ratschek M; Ambros PF
    Cancer; 1996 Apr; 77(7):1395-401. PubMed ID: 8608521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term follow-up of neuroblastoma in children less than 18 months of age].
    Zhao J; Pan C; Xu M; Zhou M; Gao YJ; Hu WT; Tang JY
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):754-759. PubMed ID: 29050113
    [No Abstract]   [Full Text] [Related]  

  • 14. Spontaneous regression of localized neuroblastoma detected by mass screening.
    Yamamoto K; Hanada R; Kikuchi A; Ichikawa M; Aihara T; Oguma E; Moritani T; Shimanuki Y; Tanimura M; Hayashi Y
    J Clin Oncol; 1998 Apr; 16(4):1265-9. PubMed ID: 9552024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroblastoma in Turkish children: experience of a single center.
    Aydn GB; Kutluk MT; Yalçn B; Büyükpamukçu M; Kale G; Varan A; Akyüz C; Senocak ME; Büyükpamukçu N
    J Pediatr Hematol Oncol; 2009 Jul; 31(7):471-80. PubMed ID: 19564739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital stage 1 neuroblastoma evolved into stage 4s.
    Schiavetti A; Foco M; Ingrosso A; Chiriacò D; Ballesio L
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):59-60. PubMed ID: 19125091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
    Nickerson HJ; Matthay KK; Seeger RC; Brodeur GM; Shimada H; Perez C; Atkinson JB; Selch M; Gerbing RB; Stram DO; Lukens J
    J Clin Oncol; 2000 Feb; 18(3):477-86. PubMed ID: 10653863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of a long-term follow-up of an observation program for neuroblastoma detected by mass screening.
    Tanaka M; Kigasawa H; Kato K; Ijiri R; Nishihira H; Aida N; Ohama Y; Tanaka Y
    Pediatr Blood Cancer; 2010 Apr; 54(4):573-8. PubMed ID: 20049932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study.
    Yoneda A; Oue T; Imura K; Inoue M; Yagi K; Kawa K; Nishikawa M; Morimoto S; Nakayama M
    Med Pediatr Oncol; 2001 Jan; 36(1):160-2. PubMed ID: 11464874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.